Clene (CLNN) Current Assets (2019 - 2026)
Clene (CLNN) posted Current Assets of $14.9 million for Q2 2026, up 66.14% on a QoQ basis from $9.0 million in Q4 2025, and up 24.44% year-over-year from $12.0 million in Q2 2025.
Analysis
Clene (CLNN) Current Assets (2019 - 2026) Analysis & Trends
Clene has reported Current Assets for 8 years, with the latest figure at $14.9 million in Q2 2026.
- On a quarterly basis, Current Assets rose 24.44% year-over-year to $14.9 million in Q2 2026; TTM through Jun 2026 was $14.9 million, a 24.44% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, down 44.44% from the prior year.
- Current Assets was $14.9 million for Q2 2026 at Clene, up from $9.0 million in the prior quarter.
- The five-year high for Current Assets was $53.4 million in Q2 2023, with the low at $9.0 million in Q4 2025.
- Average Current Assets over 5 years is $26.3 million, with a median of $24.8 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Current Assets sank 67.14% in 2022, then soared 116.17% in 2023.
- Over 5 years, Current Assets stood at $29.2 million in 2022, then jumped by 33.08% to $38.9 million in 2023, then slumped by 58.41% to $16.2 million in 2024, then sank by 44.44% to $9.0 million in 2025, then soared by 66.14% to $14.9 million in 2026.
- The last three Current Assets figures came in at $14.9 million (Q2 2026), $9.0 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 4.03 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 14.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.91 Mn |
| Dec 31, 2025 | 8.98 Mn |
| Sep 30, 2025 | 12.67 Mn |
| Jun 30, 2025 | 11.99 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | 16.16 Mn |
| Sep 30, 2024 | 19.70 Mn |
| Jun 30, 2024 | 27.91 Mn |
| Mar 31, 2024 | 32.11 Mn |
| Dec 31, 2023 | 38.85 Mn |
| Sep 30, 2023 | 46.45 Mn |
| Jun 30, 2023 | 53.37 Mn |
| Mar 31, 2023 | 24.82 Mn |
| Dec 31, 2022 | 29.20 Mn |
| Sep 30, 2022 | 21.49 Mn |
| Jun 30, 2022 | 31.59 Mn |
| Mar 31, 2022 | 42.45 Mn |
| Dec 31, 2021 | 54.58 Mn |
| Sep 30, 2021 | 65.39 Mn |
| Jun 30, 2021 | 68.16 Mn |